Award

Pagliarini chanced into groundbreaking mitochondrial research

He won the ASBMB's 2020/2021 Earl and Thressa Stadtman Young Scholar Award
Gelareh (Abulwerdi)  Vinueza
Nov. 1, 2019

Dave Pagliarini’s research career had a bumpy start. By his third year of graduate school, he had followed his advisers to three labs across the Midwest and West Coast. He finished his Ph.D. in biomolecular sciences at the University of California, San Diego. Pagliarini learned a lot from each adviser, he said, and “those challenges became my accelerators.”

Those accelerators have propelled him through almost a decade of productive mitochondria research, for which Pagliarini will receive the American Society for Biochemistry and Molecular Biology’s 2020/2021 Earl and Thressa Stadtman Young Scholar Award.

Morgridge Institute for Research
Dave Pagliarini

Pagliarini got into mitochondria research by chance when, as a grad student, he identified a new mitochondrial phosphatase that plays a critical role in biosynthesis of the essential cardiolipin required for optimal mitochondrial bioenergetics. This discovery led him to look for other mitochondrial proteins with unknown functions that could play a role in mitochondrial diseases.

Mitochondrial diseases affect one in every 4,000 individuals; uncharacterized mitochondrial proteins contribute to diseases such as mitochondrial encephalomyopathy, a neurodegenerative disorder for which there are no curative treatments.

During his postdoc in Vamsi Mootha’s laboratory at Harvard, Pagliarini established a compendium of more than 1,000 mitochondrial proteins by combining in-depth computational biology and biochemistry. He called it MitoCarta and published his findings in the journal Cell. Although this approach at first provided only a descriptive dataset, what set Pagliarini apart from others in his field was “his ability … to gain understanding of underlying cellular, biochemical, and physiological processes and mechanisms,” Christopher Newgard wrote in a letter supporting the award nomination.

Pagliarini is now the lead investigator and Arthur C. Nielsen chair of metabolism at the Morgridge Institute for Research. His lab works to discover additional orphan mitochondrial proteins and characterize them from molecular to organ level.

MitoCarta: the key to unlock mitochondrial diseases

Dave PagliariniAs a postdoc, Dave Pagliarini led the development of MitoCarta, a compendium providing an extensive map of mitochondrial proteins. Since then, his lab has become known for using systematic lipidomics, proteomics and metabolomics screens to study the effects of the loss of individual mitochondrial proteins and then digging into those proteins’ biochemical activities. One example is the team’s analysis of the biosynthetic pathway that generates coenzyme Q.

Coenzyme Q, or CoQ, a lipid member of the mitochondrial electron transport chain remarkable for its redox activity, was discovered in the late 1950s just down the street from Pagliarini’s laboratory in Madison, Wisconsin. Although this unusual lipid is involved in myriad mitochondrial diseases, its biosynthesis and transport are not completely understood, which makes understanding the associated diseases difficult.

Mapping the CoQ synthesis pathway led Pagliarini’s lab to discover the functions of multiple orphan proteins. One is CoQ9, a lipid chaperone that binds to CoQ intermediates and is essential for its biosynthesis. Another is CoQ8A, an atypical kinase/ATPase essential for the assembly of the CoQ biosynthetic complex. Each of these proteins has been shown to play a role in mitochondrial diseases.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Gelareh (Abulwerdi)  Vinueza

Gelareh (Abulwerdi) Vinueza graduated with her Ph.D. from the molecular medicine program at the University of Maryland, Baltimore. She is currently a policy fellow at the Food and Drug Administration. She has been an ASBMB volunteer writer since 2018 and is passionate about science communication and science policy. Outside of work, she enjoys photography, hiking and cooking.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

ASBMB delegates leave their mark on policymaking
Feature

ASBMB delegates leave their mark on policymaking

Dec. 1, 2022

Advocacy Training Program participants use their new skills to improve their institutional environments, create new programs, draft policy recommendations, perform targeted outreach and more.

2022 Sewer scholarship winners announced
Society News

2022 Sewer scholarship winners announced

Nov. 28, 2022

The $2,000 award goes to undergraduates who demonstrate an interest in the fields of biochemistry and molecular biology and enhance the diversity of science.

Brought to you (mostly) by and for women
Annual Meeting

Brought to you (mostly) by and for women

Nov. 23, 2022

The ASBMB’s Women in Biochemistry and Molecular Biology Committee has big plans for Discover BMB 2023.

Dedicated to sharing science
Student Chapters

Dedicated to sharing science

Nov. 21, 2022

Introduced to scientific research through her Tufts University ASBMB Student Chapter, Lema Abuoqab works to make sure other students can have the same experience.

Tolbert named HHMI VP; new phase for Hannun
Member News

Tolbert named HHMI VP; new phase for Hannun

Nov. 21, 2022

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

What’s in the structural vaccine designer’s toolbox?
Interview

What’s in the structural vaccine designer’s toolbox?

Nov. 17, 2022

Structural biologist Jason McLellan, a researcher at UT Austin, has been recognized widely for his work on vaccine development. We asked him about the nuts and bolts of engineering the best antigen.